Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology?

por McKinney, Ross, Korn, David
Publicado 2005

Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors

por Yin, Dwight E., Ludema, Christina, Cole, Stephen R., Golin, Carol E., Miller, William C., Warshaw, Meredith G., McKinney, Ross E.
Publicado 2020

Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USA

por Fong, Zhi Ven, Qadan, Motaz, McKinney, Ross, Griggs, Cornelia L., Shah, Paresh C., Buyske, Jo, Sachdeva, Ajit K., Callery, Mark P., Altieri, Maria S.
Publicado 2020

Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children

por Goulder, Philip J.R., Tang, Yanhua, Brander, Christian, Betts, Michael R., Altfeld, Marcus, Annamalai, Ken, Trocha, Alicja, He, Suqin, Rosenberg, Eric S., Ogg, Graham, O'Callaghan, Christopher A., Kalams, Spyros A., McKinney, Ross E., Mayer, Kenneth, Koup, Richard A., Pelton, Stephen I., Burchett, Sandra K., McIntosh, Kenneth, Walker, Bruce D.
Publicado 2000